Shanghai Rendu Biotechnology Co., Ltd. was established in 2007. It is a high-tech enterprise specializing in RNA molecular diagnosis technology and products in China. The company isjointly founded by Chinese-American scientists and domestic entrepreneurs. It is committed to developing and promoting RNA molecular diagnosis products based on real-time fluorescence isothermal amplification detection technology (SAT technology for short). Rendu Biology has developed and produced a set of core technologies of independent intellectual property rights from diagnostic reagents to fully automatic supporting instruments. At present, the company has successfully established the SAT technology platform, 17 related patents have been authorized, and 10 products have obtained CFDA registration certificates and are listed for sale. Compared with DNA molecular diagnosis technology (PCR), SAT technology has the characteristics of high sensitivity, strong specificity, low cross-contamination and easy realization of full-automatic high-throughput detection. Molecular diagnostic products based on SAT technology can be widely used in clinical testing, blood screening, food safety testing, emergency prevention and control of infectious diseases, rapid response and other fields.
